Badreddin Edris is Chief Operating Officer of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 229,600 shares of SWTX, which is worth approximately $7.6 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 20,000 shares (Common Stock) at a price of $41.1 per share, resulting in proceeds of $822,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 230K
8.01% 3M change
3.21% 12M change
Total Value Held $7.6 Million

Badreddin Edris Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2024
SELL
Open market or private sale
$822,000 $41.1 p/Share
20,000 Reduced 8.01%
229,600 Common Stock
Jun 03 2024
SELL
Open market or private sale
$817,200 $40.86 p/Share
20,000 Reduced 7.42%
249,600 Common Stock
Jan 08 2024
SELL
Payment of exercise price or tax liability
$227,002 $41.53 p/Share
5,466 Reduced 1.99%
269,600 Common Stock
Jan 05 2024
SELL
Payment of exercise price or tax liability
$169,643 $37.96 p/Share
4,469 Reduced 1.6%
275,066 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
42,312 Added 13.15%
279,535 Common Stock
Jan 07 2023
SELL
Payment of exercise price or tax liability
$39,166 $26.41 p/Share
1,483 Reduced 0.62%
237,223 Common Stock
Jan 06 2023
SELL
Payment of exercise price or tax liability
$91,531 $27.52 p/Share
3,326 Reduced 1.37%
238,706 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
33,994 Added 12.32%
242,032 Common Stock
Jan 07 2022
SELL
Payment of exercise price or tax liability
$141,888 $56.06 p/Share
2,531 Reduced 0.77%
325,134 Common Stock
Jan 06 2022
BUY
Grant, award, or other acquisition
-
26,124 Added 7.38%
327,665 Common Stock
Jul 01 2021
SELL
Open market or private sale
$2,731,200 $85.35 p/Share
32,000 Reduced 9.59%
301,541 Common Stock
Jan 25 2021
SELL
Open market or private sale
$2,690,240 $84.07 p/Share
32,000 Reduced 10.9%
261,542 Common Stock
Jan 07 2021
BUY
Grant, award, or other acquisition
-
13,000 Added 4.24%
293,542 Common Stock

Also insider at

EWTX
Edgewise Therapeutics, Inc. Healthcare
BE

Badreddin Edris

Chief Operating Officer
Stamford, CT

Track Institutional and Insider Activities on SWTX

Follow SpringWorks Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SWTX shares.

Notify only if

Insider Trading

Get notified when an Spring Works Therapeutics, Inc. insider buys or sells SWTX shares.

Notify only if

News

Receive news related to SpringWorks Therapeutics, Inc.

Track Activities on SWTX